2m 2m 2m 2m 2m 2m 2m
TAKEDA PHARM SP ADR (TAK)
NYSE
$15.83+$0.35 (+2.29%)
Price as of Jun 23, 2026 4:10 PM EDT- $48.9BMarket Cap
- 7.46%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
TAKEDA PHARM SP ADR (TAK)
$15.83+$0.35 (+2.29%)
TAK | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $15.47 | ||
Change | -$0.16 (-1.02%) | ||
Open | $15.49 | ||
High | $15.60 | ||
Low | $15.39 | ||
Previous Close | $15.63 | ||
Volume | 2,351,299 | ||
30-Day Average Volume | 2,975,079 | ||
1-Week Change | -1.90% | ||
1-Month Change | -4.80% | ||
1-Year Change | 7.46% | ||
3-Year Change | 7.16% | ||
5-Year Change | 12.03% | ||
Fundamentals | |||
Shares Outstanding | 3.2B | ||
Total Assets | $15.5T | ||
Market Cap | $48.9B | ||
Enterprise Value | -$546.2B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | N/A | ||
Free Cash Flow | N/A | ||
EBIT | N/A | ||
EBITDA | N/A | ||
Net Working Capital | N/A | ||
EPS | N/A | ||
Enterprise Value/EBITDA | N/A | ||
Enterprise Value/Revenue | N/A | ||
P/B | N/A | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | N/A | ||
Price/Operating Cash Flow | N/A | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | 10.41% | ||
Trailing Annual Dividend Yield | 2.08% | ||
Ex-Dividend Date | 09/30/2025 | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue
Annual Dividend Yield